Drug
Vesicare
Vesicare is a pharmaceutical drug with 4 clinical trials. Historical success rate of 75.0%.
Total Trials
4
Max Phase
—
Type
DRUG
Molecule
—
Success Metrics
Clinical Success Rate
75.0%
Based on 3 completed trials
Completion Rate
75%(3/4)
Active Trials
0(0%)
Results Posted
67%(2 trials)
Terminated
1(25%)
Phase Distribution
Ph phase_3
1
25%
Ph not_applicable
2
50%
Phase Distribution
0
Early Stage
0
Mid Stage
1
Late Stage
Phase Distribution3 total trials
Phase 3Large-scale testing
1(33.3%)
N/ANon-phased studies
2(66.7%)
Highest Phase Reached
Phase 3Trial Status & Enrollment
Completion Rate
75.0%
3 of 4 finished
Non-Completion Rate
25.0%
1 ended early
Currently Active
0
trials recruiting
Total Trials
4
all time
Status Distribution
Completed(3)
Terminated(1)
Detailed Status
Completed3
Terminated1
Development Timeline
Analytics
Development Status
Total Trials
4
Active
0
Success Rate
75.0%
Most Advanced
Phase 3
Trials by Phase
Phase 31 (33.3%)
N/A2 (66.7%)
Trials by Status
completed375%
terminated125%
Recent Activity
0 active trials
Showing 4 of 4
completedphase_3
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
NCT00454896
completed
Post Marketing Survey of Vesicare in Japan
NCT01489709
completednot_applicable
Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)
NCT01215721
terminatednot_applicable
Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy
NCT00581061
Clinical Trials (4)
Showing 4 of 4 trials
NCT00454896Phase 3
A Multicenter VESIcare® Efficacy and Safety Study for the Treatment of Urgency Associated With Overactive Bladder (OAB)
NCT01489709
Post Marketing Survey of Vesicare in Japan
NCT01215721Not Applicable
Study to Determine Effects of Vesicare on Return to Continence Post - Radical Prostatectomy (Part II)
NCT00581061Not Applicable
Study to Determine Effects of Vesicare on Return to Continence Post- Radical Prostatectomy
All 4 trials loaded
Drug Details
- Intervention Type
- DRUG
- Total Trials
- 4